Detalhe da pesquisa
1.
TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment.
Nucleic Acids Res;
47(7): 3365-3382, 2019 04 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30698737
2.
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.
BMC Cancer;
19(1): 747, 2019 Jul 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31362705
3.
SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage.
Nucleic Acids Res;
45(4): 1820-1834, 2017 02 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27923994
4.
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells.
Gut;
67(5): 903-917, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28389531
5.
Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.
Breast Cancer Res;
20(1): 59, 2018 06 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29921315
6.
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
J Transl Med;
16(1): 22, 2018 02 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29402328
7.
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer.
J Pathol;
241(3): 350-361, 2017 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27859262
8.
Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.
J Cell Physiol;
232(8): 2246-2252, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27987320
9.
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
Int J Cancer;
140(11): 2587-2595, 2017 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28233295
10.
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.
BMC Cancer;
17(1): 101, 2017 Feb 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28166748
11.
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial.
J Cell Physiol;
231(11): 2541-7, 2016 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27187274
12.
Anthropometric, metabolic and molecular determinants of human epidermal growth factor receptor 2 expression in luminal B breast cancer.
J Cell Physiol;
230(8): 1708-12, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25510909
13.
The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications.
Expert Rev Mol Med;
17: e14, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26136233
14.
Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors.
Proc Natl Acad Sci U S A;
109(47): 19280-5, 2012 Nov 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23129656
15.
Gene status in HER2 equivocal breast carcinomas: impact of distinct recommendations and contribution of a polymerase chain reaction-based method.
Oncologist;
19(11): 1118-26, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25323485
16.
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
Breast Cancer Res Treat;
148(1): 73-80, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25238881
17.
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study.
Breast Cancer Res Treat;
147(3): 599-607, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25234842
18.
Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation.
Cancer Cell;
10(3): 191-202, 2006 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16959611
19.
Cancer stem cells: are they responsible for treatment failure?
Future Oncol;
10(13): 2033-44, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25396775
20.
Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy.
Int J Cancer;
132(5): 1022-31, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22847294